drugset / Trial / NCT06593366
Fecal Microbiota Transplant for Anorexia Nervosa
Not yet recruiting
20 enrolled
Hamilton Health Sciences Corporation
Hamilton Academic Health Sciences Organization · collabMcMaster University · collab
RandomizedParallel-groupQuadruple-blindOther
Summary
The purpose of this pilot randomized-controlled trial is to determine whether Fecal Microbiota Transplant (FMT) treatment demonstrates feasibility, acceptability, and prelinary effectiveness among patients with anorexia nervosa (AN). Specifically, the investigators aim to compare changes in weight, gut microbiome, urine, blood biomarkers and mood symptoms between participants receiving the FMT intervention and placebo.
Timeline
- Start
- 2026-06-01
- Primary completion
- 2027-06-01
- Completion
- 2027-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fecal Microbiota Transplant | Other / unclassified | 15 g | Oral |